3-[4-Methyl-6-oxo-2-(pyridin-4-yl)-1,6-dihydropyrimidin-5-yl]propanoic acid hydrochloride

Catalog No. :
ACTXCR572
CAS No. :
1311315-21-5
Molecular Formula :
C13H14ClN3O3
Molecular Weight :
295.73

IUPAC Name:3-(4-methyl-6-oxo-2-(pyridin-4-yl)-1,6-dihydropyrimidin-5-yl)propanoic acid hydrochloride

3-[4-Methyl-6-oxo-2-(pyridin-4-yl)-1,6-dihydropyrimidin-5-yl]propanoic acid hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$87.00Login to see priceInquiryInquiry
100mg95%$125.00Login to see priceInquiryInquiry
250mg95%$169.00Login to see priceInquiryInquiry
1g95%$427.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-[4-Methyl-6-oxo-2-(pyridin-4-yl)-1,6-dihydropyrimidin-5-yl]propanoic acid hydrochloride
IUPAC Name3-(4-methyl-6-oxo-2-(pyridin-4-yl)-1,6-dihydropyrimidin-5-yl)propanoic acid hydrochloride
MDL No.MFCD18785555
Molecular FormulaC13H14ClN3O3
Molecular Weight295.73
SMILESO=C(O)CCC1=C(C)N=C(C2=CC=NC=C2)NC1=O.[H]Cl
InChI KeyBENUJDYJJPJUGI-UHFFFAOYSA-N
Synonym3-[4-methyl-6-oxo-2-(pyridin-4-yl)-1,6-dihydropyrimidin-5-yl]propanoic acid hydrochloride
CAS No.1311315-21-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTXCR572 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTXCR572 route product structure diagram
    ACTXCR5721311315-21-5
Inquiry

2. ACTXCR572 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTXCR572 route product structure diagram
    ACTXCR5721311315-21-5
Inquiry

Comments (0)